Patent: 10,154,813
✉ Email this page to a colleague
Summary for Patent: 10,154,813
Title: | Method and apparatus for patient skin color monitoring and drug efficacy measurement |
Abstract: | Methods and apparatus for determining the efficacy of a drug by diagnosing cardiovascular health in a patient by monitoring changes in skin redness levels, which is associated with perfusion and ability of circulatory system to adapt to physical exertion. Color detectors including colorimeters and spectrophotometers may be used to monitor and quantify skin color. Wet run solutions such as acetylcholine solutions may be applied to the skin area being monitored. Skin redness can be monitored during the course of exercise or a stress test, as well as during recovery. Wearable color detector devices can be worn by patients during exercise. |
Inventor(s): | Kokolis; Spyros (Brooklyn, NY) |
Application Number: | 16/015,057 |
Patent Claims: | see list of patent claims |
Details for Patent 10,154,813
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | September 25, 1998 | 10,154,813 | 2037-07-03 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | February 10, 2017 | 10,154,813 | 2037-07-03 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | November 02, 1998 | 10,154,813 | 2037-07-03 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | May 27, 1999 | 10,154,813 | 2037-07-03 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | September 27, 2004 | 10,154,813 | 2037-07-03 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | February 01, 2007 | 10,154,813 | 2037-07-03 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |